Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Glimepiride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glimepiride 4mg tablets
0601021A0AAADAD
|
Glimepiride | Glimepiride | Endocrine System | 38,031 |
|
Glimepiride 2mg tablets
0601021A0AAAAAA
|
Glimepiride | Glimepiride | Endocrine System | 30,900 |
|
Glimepiride 1mg tablets
0601021A0AAABAB
|
Glimepiride | Glimepiride | Endocrine System | 24,137 |
|
Glimepiride 3mg tablets
0601021A0AAACAC
|
Glimepiride | Glimepiride | Endocrine System | 15,132 |
|
Amaryl 1mg tablets
0601021A0BBABAB
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 2mg tablets
0601021A0BBAAAA
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 3mg tablets
0601021A0BBACAC
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 4mg tablets
0601021A0BBADAD
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Glimepiride 2mg/5ml oral liquid
0601021A0AAAGAG
|
Glimepiride | Glimepiride | Endocrine System | No data available |
|
Glimepiride 6mg/5ml oral suspension
0601021A0AAAHAH
|
Glimepiride | Glimepiride | Endocrine System | No data available |
|
Niddaryl 1mg tablets
0601021A0BCAAAB
|
Niddaryl | Glimepiride | Endocrine System | No data available |
|
Niddaryl 2mg tablets
0601021A0BCABAA
|
Niddaryl | Glimepiride | Endocrine System | No data available |
|
Niddaryl 3mg tablets
0601021A0BCACAC
|
Niddaryl | Glimepiride | Endocrine System | No data available |
|
Niddaryl 4mg tablets
0601021A0BCADAD
|
Niddaryl | Glimepiride | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.